To include your compound in the COVID-19 Resource Center, submit it here.

Aventis, Bayer, Schering deal

BAYG completed its previously announced acquisition of Aventis

Read the full 85 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE